FEATURES OF CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS WITH MYASTHENIA GRAVIS

Maksudova H.N.; Ergasheva N.O.; Umarova D.B.

doi:10.5281/zenodo.11138212

Maksudova H.N., Ergasheva N.O., Umarova D.B.

Abstract. Myasthenia gravis is characterized by episodes of muscle weakness and fatigue, which are based on the destruction of acetylcholine receptors by factors of humoral and cellular immunity. It is more common in young women and older men, although it can develop in people of any gender and age. Symptoms worsen with muscle activity and improve with rest. Diagnosis is based on measurement of serum levels of acetylcholine receptor (AChR) antibodies, electromyography and bedside tests (ice test, rest test).

Keywords: myasthenia gravis, AChR, diagnosis, Proserpine test.

References:

Epidemiologic studies of myasthenia gravis T.M. Aleekseev, V.V. Kryuchkov, T.R. Stuchevskaya, A.N. Khalmurzina (https://www.proquest.com/openview/c3dee6a41cba95ff67ec8dc535e0a999/1?pq-origsite=gscholar&cbl=4431309) 2. 2.V.M. Shkolnik, A.I. Kalbus, A.N. Baranenko et al. Myasthenia gravis: modern approaches to diagnosis and treatment // Ukrainian Neurological Journal. - 2014. - № 2. - С. 12-17.3Heldal AT, Eide GE, Gilhus NE, Romi F. Geographical distribution of a seropositive .myasthenia gravis population. Muscle Nerve. 2012;45:815-819. 3. Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010;10:46. 4. (https://ponervu.ru/otdeleniya-i-centry/obshhaya-nevrologiya/miasteniya) 5. V.V. Boyko, N.P. Voloshina, O.V. Egorkina et al. Modern views on the diagnosis and treatment of myasthenia gravis// NeuroNews, 1(12).-2009.. 6. Clinical guidelines Myasthenia gravis: Association of British Neurologists’ management guidelines Jon Sussman,Maria E Farrugia, Paul Maddison, Marguerite, M Isabel Leite, David Hilton-Jones. http://dx.doi.org/10.1136/ practneurol-2015.-001126.